Kno2’s Pursuit for QHIN Designation

Jeffrey Stolte

Board Member

Jeff is Managing Partner at Providence Ventures – Providence’s $300M venture capital fund. He joined Providence in 2014 to stand up the organization’s first-ever VC fund, where he leads healthcare technology investments and manages fund operations. Jeff is currently a Board Director at Trilliant, Intelligent Retinal Imaging Systems (IRIS), SpineZone, Kno2, and Ready, Set, Food! and is a Board Observer at Protenus. He previously served on the Board of Directors of InDemand Interpreting, Binary Fountain, and was an observer at Collective Medical Technologies prior to PV’s exit from those investments to various acquirers.

Prior to joining PV, Jeff was an Investment Manager at Ascension Ventures in St. Louis, MO, where he also focused on the health care technology industry. During his tenure at Ascension Ventures, Jeff served as a Director at Advanced Practice Strategies and a Board Observer at GetWellNetwork, CHF Solutions and OptiScan Biomedical Corporation.

Before Ascension Ventures, Jeff was a member of Ascension Health’s Strategic Development Group, where he contributed to numerous system-level strategic initiatives and business development activities. He also has prior experience in software product management and business development for entrepreneurial healthcare technology companies WebMD, WellMed, and HealthLanguage (formerly, CyberPlus).

Jeff holds an MBA from the University of Chicago’s Booth School of Business, an M.S. in Medical Informatics from the Oregon Health & Science University, and an A.B. from The University of Chicago.